These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 19898644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF, Duprez D, Purkayastha D, Samuel R, Ferdinand KC.
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 4. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M, Crikelair N, Yen J, Glazer R.
    Vasc Health Risk Manag; 2010 Sep 07; 6():821-7. PubMed ID: 20859551
    [Abstract] [Full Text] [Related]

  • 5. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Sep 07; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 6. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
    Weir MR, Ferdinand KC, Flack JM, Jamerson KA, Daley W, Zelenkofske S.
    Hypertension; 2005 Sep 07; 46(3):508-13. PubMed ID: 16116046
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 07; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
    Malacco E, Varì N, Capuano V, Spagnuolo V, Borgnino C, Palatini P, Val-Syst study.
    Clin Ther; 2003 Nov 07; 25(11):2765-80. PubMed ID: 14693303
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
    Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, Izzo JL.
    J Clin Hypertens (Greenwich); 2008 Mar 07; 10(3):185-94. PubMed ID: 18326958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE, Scott LJ.
    Am J Cardiovasc Drugs; 2009 Mar 07; 9(5):309-30. PubMed ID: 19791840
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P, Malacco E, Fogari R, Carretta R, Bonaduce D, Bertocchi F, Mann J, Condorelli M, Italian Collaborative Study Group.
    J Hypertens; 2001 Sep 07; 19(9):1691-6. PubMed ID: 11564991
    [Abstract] [Full Text] [Related]

  • 13. Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy.
    Weinberger MH, Glazer RD, Crikelair NA, Chiang YT.
    J Hum Hypertens; 2010 Dec 07; 24(12):823-30. PubMed ID: 20182456
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.
    Vasc Health Risk Manag; 2011 Dec 07; 7():701-8. PubMed ID: 22174580
    [Abstract] [Full Text] [Related]

  • 15. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA, Lacourcière Y, Crikelair N, Jia Y, Glazer RD.
    Curr Med Res Opin; 2013 Aug 07; 29(8):901-10. PubMed ID: 23721363
    [Abstract] [Full Text] [Related]

  • 16. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 07; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 17. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun 07; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 18. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 07; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 19. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED.
    Am J Cardiovasc Drugs; 2009 Apr 07; 9(6):411-8. PubMed ID: 19929039
    [Abstract] [Full Text] [Related]

  • 20. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.
    Hypertension; 2009 Jul 07; 54(1):32-9. PubMed ID: 19470877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.